Mapping large numbers of results may take a few moments.
|Company BioCytics Inc.||Activity: Research and Development||Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is incubated within the Carolina BioOncology Institute.||Location Huntersville|
|Company Life Edit Therapeutics||Activity: Research and Development||Company Description Life Edit Therapeutics leverages its bioinformatic pipeline to identify novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships.||Location Morrisville|
|Company Locus Biosciences Inc.||Activity: Research and Development||Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed.||Location Morrisville|